RE:CC Pharma’s Growth Potential Had Started Commencing Savage97 wrote: Last quarter, CC Pharma, saw a 50% increase in its sales of medical marijuana in March alone, the company's cannabis products overall were 13.6% more profitable than its previous quarter. This was the fourth consecutive quarter of adjusted EBITDA growth for Aphria. The company is also doing great in achieving profitability, with a net income of CA$5.7 million during the quarter. As for production capacity, Aphria sold 14,014 kilograms of cannabis products with an average selling price of CA$5.46 per gram g for adult-use cannabis and CA$6.41 per gram g for medical cannabis. Aphria's gross margin for the quarter was 42.7%, the company has more than CA$515 million on its balance sheet.
That was mentionned during the conference call by the CEO, Irwin Simon. Don't forget to put the links please
https://www.fool.com/earnings/call-transcripts/2020/04/15/aphria-inc-apha-q3-2020-earnings-call-transcript.aspx